IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MONICO, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1212
NA - Nord America 660
AS - Asia 275
SA - Sud America 10
Totale 2157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 630
GB - Regno Unito 598
CN - Cina 162
DE - Germania 148
SE - Svezia 137
IT - Italia 82
UA - Ucraina 54
DK - Danimarca 50
TR - Turchia 36
IE - Irlanda 34
CA - Canada 30
FR - Francia 28
RU - Federazione Russa 27
EU - Europa 26
IN - India 25
KR - Corea 23
BE - Belgio 17
NL - Olanda 15
FI - Finlandia 14
VN - Vietnam 10
CO - Colombia 9
HK - Hong Kong 6
ID - Indonesia 4
UZ - Uzbekistan 3
GR - Grecia 2
JP - Giappone 2
RO - Romania 2
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
EC - Ecuador 1
IL - Israele 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 2183
Salva come PNG Salva come JPEG
Città #
Southend 574
Chandler 175
Beijing 57
Ann Arbor 54
Princeton 46
Seattle 45
Jacksonville 41
Dublin 34
Milan 32
Wilmington 30
Toronto 26
Dearborn 24
Mountain View 22
Des Moines 20
Redmond 18
Brussels 17
Nanjing 15
Serra 13
Andover 12
Boardman 12
Nanchang 12
Jinan 11
Sakarya 11
Shenyang 11
Woodbridge 11
Grafing 10
Phoenix 10
Saint Petersburg 10
Somerville 10
Bogotá 9
Ashburn 6
Central District 6
Fairfield 6
Hebei 6
Houston 6
Tianjin 6
Jiaxing 5
Vobbia 5
Changsha 4
Hefei 4
Sunnyvale 4
Fremont 3
Hangzhou 3
Lanzhou 3
Ottawa 3
San Diego 3
Bitonto 2
Genoa 2
Guangzhou 2
Haikou 2
Iasi 2
Kunming 2
Magenta 2
Margão 2
Mumbai 2
Palaiseau 2
Shanghai 2
Taiyuan 2
Tokyo 2
Athens 1
Auburn Hills 1
Berlin 1
Bristol 1
Cambridge 1
Cornate D'adda 1
Cusano Milanino 1
Gavirate 1
Hamburg 1
Hanoi 1
Hanover 1
Hyderabad 1
Kochi 1
New York 1
Novate Milanese 1
Novokuznetsk 1
Phitsanulok 1
Polska 1
Putian 1
Quito 1
Rome 1
Sanluri 1
Taizhou 1
Tel Aviv 1
Vancouver 1
Verona 1
Vienna 1
Yerevan 1
Yicheng 1
Zurich 1
Totale 1501
Salva come PNG Salva come JPEG
Nome #
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis 160
Anemia during pegylated interferon-ribavirin therapy results from both increase suppression of erythroid differentiation and hemolysis 156
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegykated interferon-α2A in chronic hepatitis C : an in vitro and in vivo study 156
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients 152
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients 144
In vivo and in vitro effect of ribavirin and interferon on erythropoiesis in patients with hepatitis C 141
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients 139
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-alpha 2a in chronic hepatitis C : an in vitro and in vivo study 132
Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication? 130
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients 119
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype 118
Ribavirin impairs salivary gland function in hepatitis C patients during combination treatment with pegylated interferon alfa-2a 117
In vivo and in vitro effect of ribavirin and interferon on erythropoiesis in patients with hepatitis C 111
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 95
Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients 75
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 75
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 68
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 54
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant : a real-life strategy 51
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting 41
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 38
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 34
Response letter: Just a matter of luck? 34
Totale 2340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201868 0000 00 00 003731
2018/2019235 5027818 035 2110 2621910
2019/2020408 5171140 1626 4015 114452815
2020/2021349 22312413 3117 1748 3887921
2021/2022272 281277 1514 2019 32351271
2022/2023413 44714750 3287 417 421090
Totale 2340